Gastrointestinal Endoscopy
Volume 71, Issue 3 , Pages 513-518 , March 2010

EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy

Received 29 May 2009 ,Accepted 20 October 2009.

References 

  1. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15–36
  2. Yip D, Karapetis C, Strickland A, et al. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database Syst Rev. 2006;3:CD002093
  3. Willett CG, Czito BG, Bendell JC, et al. Locally advanced pancreatic cancer. J Clin Oncol. 2005;23:4538–4544
  4. Moertel CG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer. 1981;48:1705–1710
  5. Treatment of locally unresectable carcinoma of the pancreas. comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group. J Natl Cancer Inst. 1988;80:751–755
  6. Bakay RA. Stereotactic radiosurgery in the treatment of brain tumors. Clin Neurosurg. 1992;39:292–313
  7. Ryu SI, Chang SD, Kim DH, et al. Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions. Neurosurgery. 2001;49:838–846
  8. Koong AC, Christofferson E, Le QT, et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2005;63:320–323
  9. Koong AC, Le QT, Ho A, et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2004;58:1017–1021
  10. Kothary N, Heit JJ, Louie JD, et al. Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy. J Vasc Interv Radiol. 2009;20:235–239
  11. Chang KJ, Nguyen PT, Thompson JA, et al. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer. 2000;88:1325–1335
  12. Gan SI, Thompson CC, Lauwers GY, et al. Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointest Endosc. 2005;61:746–752
  13. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32
  14. Pishvaian AC, Collins B, Gagnon G, et al. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc. 2006;64:412–417
  15. Ellsmere J, Mahadevan A, Kelleher T, et al. EUS-guided radiotherapy fiducials for upper gastrointestinal malignancies (abstract). Gastrointest Endosc. 2007;65:AB208
  16. Yang J, Deshpande AR, Sussman DA, et al. EUS-guided fiducial placement (EUS FNF) prior to targeted radiation therapy in abdominal and pelvic tumors: a case series (abstract). Gastrointest Endosc. 2008;67:AB202–AB203
  17. Albashir S, Sawhney MS, Pleskow D, et al. EUS guided fiducial placement for cyberknife treatment of pancreatic cancer (abstract). Gastrointest Endosc. 2008;67:AB223–AB224
  18. Sanders M, Khalid A, Fasanella KE, et al. EUS-guided fiducial placement for stereotactic radiosurgery in pancreatic cancer (abstract). Gastrointest Endosc. 2008;67:AB201
  19. Olender D. Fiducials for target localization. In:  Heilbrun MP editors. Cyberknife radiosurgery: a practical guide. Sunnyvale (Calif): Cyberknife Society. 2003;p. 83–94
  20. Micames C, Jowell PS, White R, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc. 2003;58:690–695

 DISCLOSURE: W.G.P. was supported by NIH Training Grant 5T32DK007056. B.M.Y. was supported by clinical fellowships from the Canadian Institutes of Health Research and Stanford University Advanced Therapeutic Endoscopy Program. J.V.D. was supported in part by NIH/1K24 DK59799-06. The following authors disclosed financial relationships relevant to this publication: A. Koong: Honoraria and research grants from Accuray and Varian Medical Systems. D. Schellenberg: Honorarium from Accuray. The other authors disclosed no financial relationships relevant to this publication.

PII: S0016-5107(09)02684-4

doi: 10.1016/j.gie.2009.10.030

Gastrointestinal Endoscopy
Volume 71, Issue 3 , Pages 513-518 , March 2010

Article Tools

* Image Usage & Resolution